Eiger BioPharmaceuticals, Inc. Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eiger BioPharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Eiger BioPharmaceuticals, Inc. for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Foley Todd | Director | Option Exercise | C | 5.61 | 17,517 | 98,270 | 17,517 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Foley Todd | Director | Option Exercise | C | 0.45 | 218,806 | 98,244 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Foley Todd | Director | Option Exercise | C | 8.00 | 11,370 | 90,960 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Foley Todd | Director | Option Exercise | C | 0.00 | 11,788,047 | 0 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Foley Todd | Director | Buy | P | 8.00 | 111,608 | 892,864 | 1,066,775 | 955.2 K to 1.1 M (+11.68 %) |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Foley Todd | Director | Buy | C | 8.00 | 11,370 | 90,960 | 955,167 | 943.8 K to 955.2 K (+1.20 %) |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Foley Todd | Director | Buy | C | 0.00 | 943,797 | 0 | 943,797 | 0 to 943.8 K |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | WIKLUND FREDRIK | VP Corp Dvlpmnt & I ... | Buy | P | 8.00 | 20,000 | 160,000 | 20,000 | 0 to 20 K |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | PFIZER INC | 10% Owner | Option Exercise | C | 5.61 | 42,659 | 239,317 | 42,659 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | PFIZER INC | 10% Owner | Option Exercise | C | 0.45 | 532,818 | 239,235 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | PFIZER INC | 10% Owner | Option Exercise | C | 8.00 | 23,145 | 185,160 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | PFIZER INC | 10% Owner | Option Exercise | C | 0.00 | 19,289,531 | 0 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | PFIZER INC | 10% Owner | Buy | P | 8.00 | 227,261 | 1,818,088 | 1,794,803 | 1.6 M to 1.8 M (+14.50 %) |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | PFIZER INC | 10% Owner | Buy | C | 8.00 | 23,145 | 185,160 | 1,567,542 | 1.5 M to 1.6 M (+1.50 %) |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | PFIZER INC | 10% Owner | Buy | C | 0.00 | 1,544,397 | 0 | 1,544,397 | 0 to 1.5 M |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 5.61 | 25,481 | 142,948 | 25,481 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.45 | 318,266 | 142,901 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 8.00 | 16,537 | 132,296 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 17,146,250 | 0 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Novartis Bioventures Ltd | 10% Owner | Buy | P | 8.00 | 162,386 | 1,299,088 | 1,551,721 | 1.4 M to 1.6 M (+11.69 %) |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Novartis Bioventures Ltd | 10% Owner | Buy | C | 8.00 | 16,537 | 132,296 | 1,389,335 | 1.4 M to 1.4 M (+1.20 %) |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Novartis Bioventures Ltd | 10% Owner | Buy | C | 0.00 | 1,372,798 | 0 | 1,372,798 | 0 to 1.4 M |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | NARACHI MICHAEL | Director | Buy | P | 8.00 | 62,500 | 500,000 | 62,500 | 0 to 62.5 K |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Lundbeckfond Invest A/S | 10% Owner | Option Exercise | C | 5.61 | 28,666 | 160,816 | 28,666 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Lundbeckfond Invest A/S | 10% Owner | Option Exercise | C | 0.45 | 358,049 | 160,764 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Lundbeckfond Invest A/S | 10% Owner | Option Exercise | C | 8.00 | 18,605 | 148,840 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Lundbeckfond Invest A/S | 10% Owner | Option Exercise | C | 0.00 | 19,289,531 | 0 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Lundbeckfond Invest A/S | 10% Owner | Buy | P | 8.00 | 182,681 | 1,461,448 | 1,745,683 | 1.6 M to 1.7 M (+11.69 %) |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Lundbeckfond Invest A/S | 10% Owner | Buy | C | 8.00 | 18,605 | 148,840 | 1,563,002 | 1.5 M to 1.6 M (+1.20 %) |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Lundbeckfond Invest A/S | 10% Owner | Buy | C | 0.00 | 1,544,397 | 0 | 1,544,397 | 0 to 1.5 M |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Kordel Johan | Director | Option Exercise | C | 5.61 | 28,666 | 160,816 | 28,666 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Kordel Johan | Director | Option Exercise | C | 0.45 | 358,049 | 160,764 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Kordel Johan | Director | Option Exercise | C | 8.00 | 18,605 | 148,840 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Kordel Johan | Director | Option Exercise | C | 0.00 | 19,289,531 | 0 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Kordel Johan | Director | Buy | P | 8.00 | 182,681 | 1,461,448 | 1,745,683 | 1.6 M to 1.7 M (+11.69 %) |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Kordel Johan | Director | Buy | C | 8.00 | 18,605 | 148,840 | 1,563,002 | 1.5 M to 1.6 M (+1.20 %) |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Kordel Johan | Director | Buy | C | 0.00 | 1,544,397 | 0 | 1,544,397 | 0 to 1.5 M |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Funder Joshua | Director | Option Exercise | C | 5.61 | 53,807 | 301,857 | 53,807 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Funder Joshua | Director | Option Exercise | C | 0.45 | 672,060 | 301,755 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Funder Joshua | Director | Option Exercise | C | 8.00 | 23,145 | 185,160 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Funder Joshua | Director | Option Exercise | C | 0.00 | 11,788,047 | 0 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Funder Joshua | Director | Buy | P | 8.00 | 227,261 | 1,818,088 | 1,194,204 | 966.9 K to 1.2 M (+23.50 %) |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Funder Joshua | Director | Buy | C | 8.00 | 23,145 | 185,160 | 966,943 | 943.8 K to 966.9 K (+2.45 %) |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Funder Joshua | Director | Buy | C | 0.00 | 943,798 | 0 | 943,798 | 0 to 943.8 K |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Enterprise Partners Management ... | 10% Owner | Option Exercise | C | 5.61 | 20,833 | 116,873 | 20,833 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Enterprise Partners Management ... | 10% Owner | Option Exercise | C | 0.45 | 260,859 | 117,126 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Enterprise Partners Management ... | 10% Owner | Option Exercise | C | 8.00 | 13,553 | 108,424 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Enterprise Partners Management ... | 10% Owner | Option Exercise | C | 0.00 | 5,741,267 | 0 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Enterprise Partners Management ... | 10% Owner | Option Exercise | C | 0.00 | 11,573,520 | 0 | 0 | |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Enterprise Partners Management ... | 10% Owner | Buy | P | 8.00 | 133,083 | 1,064,664 | 1,950,184 | 1.8 M to 2 M (+7.32 %) |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Enterprise Partners Management ... | 10% Owner | Buy | C | 8.00 | 13,553 | 108,424 | 1,817,101 | 1.8 M to 1.8 M (+0.75 %) |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Enterprise Partners Management ... | 10% Owner | Buy | C | 0.00 | 459,668 | 0 | 1,803,548 | 1.3 M to 1.8 M (+34.20 %) |
| Feb 06 2014 | EIGR | Eiger BioPharmaceu ... | Enterprise Partners Management ... | 10% Owner | Buy | C | 0.00 | 926,621 | 0 | 1,343,880 | 417.3 K to 1.3 M (+222.07 %) |